173 related articles for article (PubMed ID: 18381431)
1. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer.
Gautschi O; Tepper CG; Purnell PR; Izumiya Y; Evans CP; Green TP; Desprez PY; Lara PN; Gandara DR; Mack PC; Kung HJ
Cancer Res; 2008 Apr; 68(7):2250-8. PubMed ID: 18381431
[TBL] [Abstract][Full Text] [Related]
2. Serum regulation of Id1 expression by a BMP pathway and BMP responsive element.
Lewis TC; Prywes R
Biochim Biophys Acta; 2013 Oct; 1829(10):1147-59. PubMed ID: 23948603
[TBL] [Abstract][Full Text] [Related]
3. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis.
Katagiri T; Imada M; Yanai T; Suda T; Takahashi N; Kamijo R
Genes Cells; 2002 Sep; 7(9):949-60. PubMed ID: 12296825
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.
Nakashima A; Katagiri T; Tamura M
J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.
Rothschild SI; Tschan MP; Federzoni EA; Jaggi R; Fey MF; Gugger M; Gautschi O
Oncogene; 2012 Sep; 31(38):4221-32. PubMed ID: 22249264
[TBL] [Abstract][Full Text] [Related]
7. HLA-B-associated transcript 3 (Bat3/Scythe) negatively regulates Smad phosphorylation in BMP signaling.
Goto K; Tong KI; Ikura J; Okada H
Cell Death Dis; 2011 Dec; 2(12):e236. PubMed ID: 22130070
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
[TBL] [Abstract][Full Text] [Related]
9. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene.
López-Rovira T; Chalaux E; Massagué J; Rosa JL; Ventura F
J Biol Chem; 2002 Feb; 277(5):3176-85. PubMed ID: 11700304
[TBL] [Abstract][Full Text] [Related]
10. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
11. WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling.
Qiu H; Yang B; Pei ZC; Zhang Z; Ding K
J Biol Chem; 2010 Oct; 285(42):32638-46. PubMed ID: 20679340
[TBL] [Abstract][Full Text] [Related]
12. FOXC1 negatively regulates BMP-SMAD activity and Id1 expression during osteoblast differentiation.
Caddy JC; Luoma LM; Berry FB
J Cell Biochem; 2020 Jun; 121(5-6):3266-3277. PubMed ID: 31916318
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells.
Valdimarsdottir G; Goumans MJ; Rosendahl A; Brugman M; Itoh S; Lebrin F; Sideras P; ten Dijke P
Circulation; 2002 Oct; 106(17):2263-70. PubMed ID: 12390958
[TBL] [Abstract][Full Text] [Related]
14. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.
Pouliot F; Labrie C
J Endocrinol; 2002 Jan; 172(1):187-98. PubMed ID: 11786386
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
[TBL] [Abstract][Full Text] [Related]
16. Nicotine-mediated invasion and migration of non-small cell lung carcinoma cells by modulating STMN3 and GSPT1 genes in an ID1-dependent manner.
Nair S; Bora-Singhal N; Perumal D; Chellappan S
Mol Cancer; 2014 Jul; 13():173. PubMed ID: 25028095
[TBL] [Abstract][Full Text] [Related]
17. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
Chen C; Qin Y; Fang JP; Ni XY; Yao J; Wang HY; Ding K
Acta Pharmacol Sin; 2015 Sep; 36(9):1053-64. PubMed ID: 26299951
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP enhances Smad-mediated BMP signaling through PKA-CREB pathway.
Ohta Y; Nakagawa K; Imai Y; Katagiri T; Koike T; Takaoka K
J Bone Miner Metab; 2008; 26(5):478-84. PubMed ID: 18758906
[TBL] [Abstract][Full Text] [Related]
19. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter.
Korchynskyi O; ten Dijke P
J Biol Chem; 2002 Feb; 277(7):4883-91. PubMed ID: 11729207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
